| Jun 4 |
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
|
| Jun 3 |
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
|
| May 31 |
Mainz Biomed Reports Results of 2024 Annual General Meeting
|
| May 29 |
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
|
| May 28 |
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
|
| May 20 |
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
|
